Sign in

CIK 0001649904

  • Large accelerated filer

RHYTHM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RYTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
462159271
Phone
+1 857-264-4280
Business address
222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
Former names
RHYTHM METABOLIC, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,849,905
in 3 filings, $12.8M under 10b5-1 plans

Net −$12,849,905. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-13 Garfield Alastair Chief Scientific Officer Sale 10b5-1 −2,007 $116.11 $233K 8,051
2026-08-13 Garfield Alastair Chief Scientific Officer Sale 10b5-1 −1,556 $117.08 $182K 6,495
2026-08-13 Garfield Alastair Chief Scientific Officer Sale 10b5-1 −3,400 $118.28 $402K 3,095
2026-08-13 Garfield Alastair Chief Scientific Officer Sale 10b5-1 −800 $119.17 $95K 2,295
2026-07-01 Garfield Alastair Chief Scientific Officer Exercise or conversion +4,445 12,208
2026-07-01 Garfield Alastair Chief Scientific Officer Shares withheld for taxes −2,150 $110.41 $237K 10,058
2026-07-01 Garfield Alastair Chief Scientific Officer Exercise or conversion · Restricted Stock Units −4,445 8,888
2026-02-11 Garfield Alastair Chief Scientific Officer Grant or award · Restricted Stock Units +16,650 16,650
2026-02-11 Garfield Alastair Chief Scientific Officer Grant or award · Stock Options (Right to Buy) +25,000 25,000
2026-02-01 Garfield Alastair Chief Scientific Officer Exercise or conversion +6,663 9,789
2026-02-01 Garfield Alastair Chief Scientific Officer Shares withheld for taxes −2,026 $108.99 $221K 7,763
2026-02-01 Garfield Alastair Chief Scientific Officer Exercise or conversion · Restricted Stock Units −6,663 19,987
2025-07-02 Garfield Alastair Chief Scientific Officer Sale 10b5-1 −1,313 $64.81 $85K 3,132
2025-07-02 Garfield Alastair Chief Scientific Officer Sale 10b5-1 −6 $64.60 $388 3,126
2025-07-01 Garfield Alastair Chief Scientific Officer Exercise or conversion 10b5-1 +4,445 4,445
2025-07-01 Garfield Alastair Chief Scientific Officer Exercise or conversion · Restricted Stock Units 10b5-1 −4,445 13,333
2025-02-14 Garfield Alastair Chief Scientific Officer Grant or award · Restricted Stock Units +26,650 26,650
2025-02-14 Garfield Alastair Chief Scientific Officer Grant or award · Stock Options (Right to Buy) +40,000 40,000
2024-07-08 Garfield Alastair Chief Scientific Officer Grant or award · Stock Option (right to buy) +53,333 53,333
2024-07-08 Garfield Alastair Chief Scientific Officer Grant or award · Restricted Stock Units +17,778 17,778

Page 1 of 1 · 20 trades